Roche Holding AG (FRA:RHO5)
Germany
· Delayed Price · Currency is EUR 331.95
-2.25 (-0.67%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Roche Pharmaceuticals Revenue | 44.59B | 43.30B |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Revenue | 2.93B | 2.87B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Revenue | 47.52B | 46.17B |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Revenue | 14.07B | 14.32B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| Switzerland Revenue | 747.00M |
Log In |
Log In |
Log In | Upgrade
|
| Germany Revenue | 2.93B |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Revenue | 10.29B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 13.97B |
Log In |
Log In |
Log In | Upgrade
|
| United States Revenue | 28.90B |
Log In |
Log In |
Log In | Upgrade
|
| Rest of North America Revenue | 889.00M |
Log In |
Log In |
Log In | Upgrade
|
| North America Revenue | 29.79B |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Revenue | 3.25B |
Log In |
Log In |
Log In | Upgrade
|
| Japan Revenue | 3.15B |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia Revenue | 9.09B |
Log In |
Log In |
Log In | Upgrade
|
| Asia Revenue | 12.24B |
Log In |
Log In |
Log In | Upgrade
|
| Africa, Australia and Oceania Revenue | 1.25B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Roche Pharmaceuticals Operating Profit | 14.13B | 12.34B |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Operating Profit | 3.16B | 3.21B |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Operating Profit | 17.63B | 15.59B |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Profit | 1.24B | 1.95B |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Profit | -4.19B | -4.12B |
Log In |
Log In |
Log In | Upgrade
|
Capital Expenditures
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Roche Pharmaceuticals Capital Expenditures | 4.98B | 6.00B |
Log In |
Log In |
Log In | Upgrade
|
| Chugai Capital Expenditures | 476.00M | 350.00M |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Capital Expenditures | 5.45B | 6.35B |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Capital Expenditures | 2.45B | 2.44B |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures | 66.00M | 78.00M |
Log In |
Log In |
Log In | Upgrade
|